Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nyxoah SA - Ordinary Shares (NQ:NYXH)

4.917 -0.103 (-2.05%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nyxoah SA - Ordinary Shares

< Previous 1 2 3 4 5 Next >
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah to Participate in Upcoming Investor Conferences
From Nyxoah
Via GlobeNewswire
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
From Nyxoah
Via GlobeNewswire
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
From Nyxoah
Via GlobeNewswire
Nyxoah Appoints Scott Holstine as Chief Commercial Officer
From Nyxoah
Via GlobeNewswire
Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank
From Nyxoah
Via GlobeNewswire
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Nyxoah to Participate in the Jefferies Global Healthcare Conference
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
From Nyxoah
Via GlobeNewswire
Information on the Total Number of Voting Rights and Shares
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Pricing of Offering
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Proposed Offering of Ordinary Shares
From Nyxoah
Via GlobeNewswire
Nyxoah Reports First Quarter 2024 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024
From Nyxoah
Via GlobeNewswire
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
From Nyxoah
Via GlobeNewswire
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
From Nyxoah
Via GlobeNewswire
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
From Nyxoah
Via GlobeNewswire
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
From Nyxoah
Via GlobeNewswire
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
From Nyxoah
Via GlobeNewswire
Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024
From Nyxoah
Via GlobeNewswire
Nyxoah Announces 2024 Strategic Priorities
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023
From Nyxoah
Via GlobeNewswire
Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®
From Nyxoah
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.